Jarislowsky, Fraser Portfolio holdings
Jarislowsky Fraser started in 1955 as a Montreal research firm that sold its stock research to investment managers in the US and UK. Its founder, Stephen Jarislowsky, was a Harvard-educated investor and former Alcan executive. The firm won its first pension fund client by 1966, and managing money for institutions became its core business. Scotiabank bought it in 2018, and the firm kept its Montreal headquarters and its investment independence. It looks for quality, sustainable businesses to hold for long-term growth, and serves pension funds, endowments, foundations, corporations and Indigenous communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$72M |
| 2 |
Gildan
GIL
|
+$70.6M |
| 3 |
Cenovus Energy
CVE
|
+$60M |
| 4 |
Pembina Pipeline
PBA
|
+$50.7M |
| 5 |
Stantec
STN
|
+$42.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$298M |
| 2 |
AGN
Allergan Inc
AGN
|
+$110M |
| 3 |
Target
TGT
|
+$74.6M |
| 4 |
Royal Bank of Canada
RY
|
+$21.8M |
| 5 |
Canadian National Railway
CNI
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.17% |
| 2 | Energy | 24.85% |
| 3 | Industrials | 13.71% |
| 4 | Technology | 9.72% |
| 5 | Healthcare | 8.23% |
Similar funds
Jarislowsky, Fraser's Q1 2015 Portfolio in Review
As of Q1 2015, Jarislowsky, Fraser held 148 positions worth $15B, down 7.3% from $16.2B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Jarislowsky, Fraser's Q1 2015 filing shows 8 new, 33 increased, 103 reduced and 2 closed positions. Its largest new stake was Gildan: 2,415,294 shares worth $71.2M. The largest sale was Potash Corp Of Saskatchewan, an estimated $298M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 32% a quarter earlier, followed by Energy and Industrials.
- Jarislowsky, Fraser's largest Q1 2015 buy was Gildan: 2,415,294 shares worth $71.2M.
- Jarislowsky, Fraser added most to Enbridge in Q1 2015, an estimated $72M increase.
- Jarislowsky, Fraser's biggest Q1 2015 reduction was Potash Corp Of Saskatchewan, cutting an estimated $298M.
- Jarislowsky, Fraser fully exited Allergan Inc in Q1 2015, selling an estimated $110M.
- Jarislowsky, Fraser's ten largest holdings make up 50% of its $15B portfolio in Q1 2015.
- Jarislowsky, Fraser opened 8 new positions and closed 2 in Q1 2015.
- Jarislowsky, Fraser's portfolio value fell 7.3% quarter-over-quarter to $15B.
Based on Jarislowsky, Fraser's 13F filing for Q1 2015, filed 13 May 2015.